Oblique Therapeutics
Pre-clinicalOblique Therapeutics. We focus on developing new antibody medicines in pain and aggressive-metastatic cancer.
Founded
2015
Focus
AntibodiesBiologicsSmall Molecules
About
Oblique Therapeutics. We focus on developing new antibody medicines in pain and aggressive-metastatic cancer.
Funding History
3Total raised: $12.2M
Series A$8.5MIndustrifondenMar 15, 2021
Grant$1.2MVinnovaJun 15, 2019
Seed$2.5MAlmi InvestJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationGothenburg, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile